42407-81-8Relevant articles and documents
Leucine rich repeat kinase 2 (LRRK2) inhibitors based on indolinone scaffold: Potential pro-neurogenic agents
Salado, Irene G.,Zaldivar-Diez, Josefa,Sebastian, Victor,Li, Lingling,Geiger, Larissa,González, Silvia,Campillo, Nuria E.,Gil, Carmen,Morales, Aixa V.,Perez, Daniel I.,Martinez, Ana
, p. 328 - 342 (2017/07/07)
Leucine-rich repeat kinase 2 (LRRK2) is one of the most pursued targets for Parkinson's disease (PD) therapy. Moreover, it has recently described its role in regulating Wnt signaling and thus, it may be involved in adult neurogenesis. This new hypothesis